Renuvion® Technology

Renuvion® in lipedema: what it is and what the evidence says

Renuvion® combines helium plasma and radiofrequency and some clinics use it alongside liposuction. It is not a treatment for lipedema, the S2k clinical guideline does not include it and the evidence on its effect on the skin is limited. This page explains what it is, what the FDA has cleared, which risks have been described and how it is considered at consultation.

Quick answer

Renuvion® and lipedema in four points

  • What it is: a device that ionises helium gas and combines it with radiofrequency to deliver energy beneath the skin.
  • What the FDA has cleared: coagulation of subcutaneous soft tissue after liposuction for aesthetic body contouring. It has not specifically cleared skin retraction on the body or the treatment of lipedema.
  • What the evidence says: a 2025 systematic review finds no reliable additional skin retraction compared with liposuction alone.
  • What the S2k lipedema guideline (2024) says: it does not mention Renuvion or other plasma or radiofrequency systems.

That is why Renuvion® is not presented here as a solution for skin laxity or as part of lipedema treatment. If it is considered, it is an optional complement to surgery and is decided case by case.

What it is

What Renuvion® (J-Plasma) is and how it works

Renuvion®, also known as J-Plasma, is a device that ionises helium gas and combines it with radiofrequency to generate a plasma applied beneath the skin. The energy heats the tissue in a controlled way, which is why it is used as an adjunct to liposuction.

In lipedema, the removal technique is liposuction (WAL or PAL), and that is the technique the clinical guideline covers. Renuvion® does not remove fat: if the team decides to use it, it is applied after the removal and within the same procedure.

It features in a lot of cosmetic surgery content, where it is sold as a skin-tightening tool. In lipedema it is worth separating what is proven from what is not, which is what this page does.

What is known

What is and is not known about Renuvion® in lipedema

AspectWhat is knownSource
FDA clearance510(k) clearance in April 2023 (K230272) of the APR handpiece for coagulation of subcutaneous soft tissue after liposuction for aesthetic body contouring. It applies to the US market.FDA
Skin retraction on the bodyNot reliably shown beyond what liposuction already achieves. Studies are mostly low-quality case series, many with ties to the manufacturer.Swanson 2025
LipedemaThere is no specific clearance and no recommendation in the S2k 2024 clinical guideline.FDA, S2k 2024
RisksBurns, seromas, haematomas, sensory changes and, because of the helium, subcutaneous emphysema have been described. Serious complications are exceptional.Swanson 2025
ContraindicationsNot listed here because the sources consulted do not detail them. They are assessed at consultation using the device instructions for use.-

Summary of the sources cited at the end of the page. Sources last reviewed: 6 November 2026.

The evidence

What the evidence says about skin retraction

Swanson's systematic review (Annals of Plastic Surgery, 2025) analysed 36 publications on helium plasma radiofrequency. Almost all are case series, chart reviews and subjective assessments, with few control groups. Its conclusion is that there is no evidence of additional skin retraction beyond that of traditional liposuction, and it notes that some published improvement percentages do not correspond to real measurements.

It is a single, critical review by one author, so it is not a consensus. But it does indicate that figures such as "up to X% retraction" have no solid basis, which is why we do not use them.

There is also a manufacturer trial of helium plasma on the neck and submental area, a different area and context (no liposuction and no control group), which cannot be extrapolated to the legs or arms.

Skin in lipedema

Skin after liposuction in lipedema: what the guideline does cover

The S2k clinical guideline on lipedema (2024) acknowledges that, in rare cases of pronounced lipedema, large folds of tissue may remain after successful liposuction. For those cases it suggests a later surgical tightening using a lymph vessel-sparing technique, and it lists slack skin among the complications reported after liposuction.

In other words, the issue exists and is addressed within surgery, not with one specific device. You can see how the whole approach fits together on the lipedema surgery page and in the Advanced Care Method.

Risks

Risks described with helium plasma and radiofrequency

The literature describes, among others, burns, seromas, haematomas and sensory changes. Because helium is used, gas build-up in the tissues (subcutaneous emphysema) has also been described and, exceptionally, serious complications. The FDA reporting database includes serious events, but it relies on voluntary reporting and cannot be used to calculate how often they occur.

As with any surgical procedure, the risks and their likelihood are explained at consultation before deciding. Suitability is assessed in person for each patient.

In practice

How it is considered at the clinic and what to expect

When Renuvion® is considered, it is applied in the same procedure, after removal with WAL and/or PAL. The usual lipedema areas are the legs and arms. The decision is individual and is assessed at consultation, at our clinic in Valencia (Gran Vía del Marqués del Turia 20).

What to expect: skin changes are gradual and vary from person to person, and no specific result can be promised. General recovery times for the surgery are on the recovery page.

Renuvion® does not cure lipedema and does not replace surgery or conservative management. Lipedema is a chronic condition with no cure, but its symptoms can be treated.

Frequently asked questions

Questions about Renuvion® in lipedema

What is Renuvion®?

It is a device that combines helium plasma and radiofrequency to deliver energy beneath the skin. It is also known as J-Plasma.

What is Renuvion® used for?

In the United States, the FDA cleared its APR handpiece in 2023 for coagulation of subcutaneous soft tissue after liposuction for aesthetic body contouring. In lipedema, some clinics use it as an optional complement to surgery.

Does Renuvion® tighten the skin?

It has not been reliably shown to. A 2025 systematic review finds no retraction beyond that of liposuction alone, and the available studies are of low quality.

Is it a treatment for lipedema?

No. It has no specific clearance for the condition and the S2k 2024 clinical guideline does not include it. At most it is considered as a complement to surgery.

Is it used on the legs?

The legs and arms are the usual lipedema areas, and that is where it would be considered if the team sees fit. There are no specific studies showing a benefit in those areas.

Can it be combined with WAL or PAL?

Yes. When it is considered, it is applied in the same procedure, after removal with WAL and/or PAL.

What are the risks?

Burns, seromas, haematomas, sensory changes, gas build-up in the tissues and, exceptionally, serious complications have been described. They are explained at consultation before deciding.

Does it have contraindications?

Yes, as with any surgical procedure. They are assessed at consultation for each patient, using the device instructions for use and the medical history.

Does the S2k guideline recommend Renuvion®?

No. The S2k lipedema guideline (2024) does not mention Renuvion® or other plasma or radiofrequency systems as part of treatment.

Does it replace surgery or lipedema treatment?

No. At most it is a complement to surgery. It does not replace the surgical approach or the conservative management of lipedema.

Medically reviewed content. Content produced by the medical team at Lipedema Advanced Care and reviewed by Dr. Alexo Carballeira Braña, plastic surgeon specialised in the treatment of lipedema. Meet Dr. Alexo Carballeira and the rest of our medical team.

This information is for educational purposes and does not replace a medical consultation or diagnosis. Lipedema is a chronic condition; it has no cure, but its symptoms can be treated. Every case requires an individualised assessment. Last updated: November 2026.

Dr. Alexo Carballeira

PERSONALISED CARE

Begin your journey to
control of lipedema

"My commitment is to offer you a precise diagnosis and complete support throughout the process."

Dr. Alexo Carballeira
Utilizamos cookies para darte la mejor experiencia en nuestra web.   
Privacidad